𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I clinical trial of continuous infusion of tyroserleutide in patients with advanced hepatocellular carcinoma

✍ Scribed by Zhen-Yu Xiao, Jin-Bin Jia, Lin Chen, Wei Zou, Xiao-Ping Chen

Book ID
118821473
Publisher
Springer US
Year
2011
Tongue
English
Weight
360 KB
Volume
29
Category
Article
ISSN
1357-0560

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II trial of gemcitabine in patie
A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma
✍ Charles S. Fuchs; Jeffrey W. Clark; David P. Ryan; Mathew H. Kulke; Haesook Kim; πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 74 KB πŸ‘ 2 views

## Abstract ## BACKGROUND There is no effective systemic therapy for patients with hepatocellular carcinoma. A recent trial reported a moderate antitumor activity for gemcitabine among Asian patients with advanced hepatocellular carcinoma. This led to our examination of the efficacy and tolerabili

A Phase II trial of nolatrexed dihydroch
A Phase II trial of nolatrexed dihydrochloride in patients with advanced hepatocellular carcinoma
✍ Keith Stuart; Judy Tessitore; Jeff Rudy; Neil Clendennin; Amanda Johnston πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 70 KB πŸ‘ 2 views

## BACKGROUND. Inoperable hepatocellular carcinoma is an incurable malignancy with no accepted standard therapy. Chemotherapy has demonstrated occasional responses and the need is great for a new and effective agent. Therefore the authors conducted this Phase II trial of a novel thymidylate syntha